Company / Cash per Share
KIORA PHARMACEUTICALS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.33
FY2025
5-year range
$0.21 / $4.43
FY2021-FY2025
Trend
-92.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 8 years, ranging from $0.21 in FY2021 to $4.43 in FY2024.
Based on SEC 10-K filings.
0.33 in FY2025 with a 5-year CAGR of +2.3%.
Improved from $0.21 to $0.33 over the past 4 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +2.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 92.7% year-over-year.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.33 | -92.7% |
| FY2024 | $4.43 | +1975.7% |
| FY2021 | $0.21 | -26.6% |
| FY2020 | $0.29 | -76.6% |
| FY2019 | $1.24 | +168.0% |
| FY2018 | $0.46 | -39.8% |
| FY2017 | $0.77 | -29.7% |
| FY2016 | $1.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026